Sort
53,477 grants matching “addiction”
Clinical Psychoneuroendocrinology and Neuropsychopharmacology (CPN)
$2,696,667Lorenzo Leggio · National Institute On Drug Abuse · ZIA · FY2025 · DA
Role of a Novel Stress Response Mechanism-Genetic Buffering-in Tumor Evolution
$2,695,500Chengkai Dai · Jackson Laboratory · DP2 · FY2010 · OD
Spinal Manipulation and Patient Self-Management to Prevent Back Pain Chronicity
$2,695,221Gert Bronfort · University Of Minnesota · UH3 · FY2019 · AT
NIDA Clinical Trials Network: New York Node
$2,693,487John P Rotrosen · New York University School Of Medicine · UG1 · FY2022 · DA
Neuroimaging Analysis Center (NAC)
$2,693,140Ron Kikinis · Brigham And Women'S Hospital · P41 · FY2013 · EB
Development of a Safer and More Effective Ibogaine Analog for the Treatment of Opioid Use Disorder
$2,692,397Gerard Joseph Marek · Gilgamesh Pharmaceuticals Inc · UG3 · FY2025 · DA
Helping to End Addiction Long-term (HEAL): Probe/Drug Lead Production
$2,687,040Matthew Hall · National Center For Advancing Translational Sciences · ZIA · FY2023 · TR
Cellular mechanisms of neuronal dysfunction in addiction and neurodegeneration
$2,685,245Brandon Harvey · National Institute On Drug Abuse · ZIA · FY2025 · DA
PRE-IND DEVELOPMENT OF PPL-103: A POTENT OPIOID ANALGESIC THAT IS SAFE, NON-ADDICTING, AND FREE OF OTHER DANGEROUS OPIOID SIDE EFFECTS
$2,684,006Phoenix Pharmalabs, Inc. · · FY2018 · Defense Health Agency
Neurobiology of Addiction
$2,682,287George Koob · National Institute On Drug Abuse · ZIA · FY2022 · DA
Support for Enhancement Excellence in Research at UPR RP
$2,680,908University Of Puerto Rico Rio Piedras · S06 · FY2005 · GM
Circuit architecture and dynamics of the insular cortex underlying motivational behaviors
$2,680,497Tianyi Mao · Oregon Health & Science University · RF1 · FY2023 · NS
Development of PPL-138, a Novel Mixed NOP/Mu Partial Agonist for Treatment of CocaineUse Disorder
$2,680,161Lawrence R Toll · Phoenix Pharmalabs, Inc. · U01 · FY2022 · DA
New Mexico Clinical Trials Node: Clinical research and practice to address substance use in diverse, rural and underserved populations
$2,679,320Kimberly Page · University Of New Mexico Health Scis Ctr · UG1 · FY2020 · DA
Medicinal Chemistry of Drugs Acting on Central and Peripheral Opioid Receptors
$2,678,466Kenner Rice · National Institute On Drug Abuse · ZIA · FY2025 · DA
Novel opioids that protect against oral overdose and disrupt the progression to misuse, abuse, and addiction
$2,677,544Thomas E Jenkins · Elysium Therapeutics, Inc. · R01 · FY2020 · DA
Substance Abuse Research - Medications Development Center
$2,676,795John G Grabowski · University Of Texas Hlth Sci Ctr Houston · P50 · FY2006 · DA
Monitoring the Future: A Cohort-Sequential Panel Study of Drug Use, Ages 19-65
$2,675,194Megan Elizabeth Patrick · University Of Michigan At Ann Arbor · R01 · FY2024 · DA
NIH Health Care Systems Research Collaboratory-Coordinating Center (U24)
$2,674,999Adrian Hernandez · Duke University · U24 · FY2025 · AT
GATHER: Growing a Tribal Healing Effort through Research
$2,674,051Myra Elizabeth Parker · University Of Washington · OT2 · FY2025 · DA
Nalmefene Implant for the Long-Term Treatment of Opioid Use Disorder
$2,666,592Katherine Beebe Devarney · Titan Pharmaceuticals, Inc. · UG3 · FY2018 · DA
Monitoring the Future: A Cohort-Sequential Panel Study of Drug Use, Ages 19-65
$2,666,307Megan Elizabeth Patrick · University Of Michigan At Ann Arbor · R01 · FY2025 · DA
GATHER: Growing a Tribal Healing Effort through Research
$2,666,052Myra Elizabeth Parker · University Of Washington · OT2 · FY2024 · DA
Development of MRI Techniques for Drug-Abuse Applications
$2,665,234Yihong Yang · National Institute On Drug Abuse · Z01 · FY2007 · DA
Development of negative allosteric modulators at the mu opioid receptor
$2,664,000Susruta Majumdar · Washington University · UG3 · FY2025 · DA